Current Review Reports是Biomed Central汇集了当今世界上各个学科的著名学者专家，根据当今各个学科的研究现状所撰写的综述性的文章，有一定的时效性和前瞻性。现将其中的动脉粥样硬化相关文章摘录如下，希望可以给各位用户带来一些新的信息。
Role of Central Mineralocorticoid Receptors in Cardiovascular Disease Serum Uric Acid As a Cardiovascular Risk Factor for Heart Disease Advances In Device Lead Extraction Alcohol and Cardiovascular Disease An Evidence-based Approach to Diagnosing Renovascular Hypertension Analysis of Dual-Chamber Pacing as a Treatment for Refractory Limiting Symptoms in Patients with Obstructive Hypertrophic Cardiomyopathy Angiotensin-converting Enzyme Inhibitor and Aspirin Interaction in Congestive Heart Failure-Fear or Reality Antiatherogenic Components of Olive Oil Antibiotic Therapy for Treatment of Chlamydia to Prevent Coronary Heart Disease Events Anticoagulant Therapy in Special Circumstances Anticoagulation and Heart Failure Anticoagulation for Acute Coronary Syndromes and Percutaneous Coronary Intervention in Patients with Heparin-induced Thrombocytopenia Antioxidants and Vitamins to Reduce Cardiovascular Disease Antiphospholipid Syndrome, Antiphospholipid Antibodies, and Atherosclerosis Antithrombotic Therapy for Prosthetic Valves-Routine Treatment and Special Considerations Antithrombotic Therapy for Valve Disease-Native and Prosthetic Valves Antithrombotic Therapy in Cardiac Stent Patients Antithrombotic Therapy in Chronic Heart Disease Antithrombotic Therapy in the Cardiac Catheterization Laboratory-Focus on Antiplatelet Agents Antithrombotics and Acute Coronary Syndromes Antithrombotics in the Management of Patients with Acute Coronary Are All b-Blockers the Same for Chronic Heart Failure Are Drugs and Catheter Ablation Effective for Treating Ventricular Arrhythmias Are Implantable Cardioverter-Defibrillators Cost-Effective Are Statins Anti-Inflammatory-Inflammation C-Reactive Protein Assessment and Management of Lipid Abnormalities Assessment of Management of Lipid Abnormalities Asymptomatic Left Ventricular Dysfunction in the Community Athletes Heart and Hypertrophic Cardiomyopathy Benefits of Niacin in Atherosclerosis Beta-Blockers and Spironolactone in Heart Failure Beta-Carotene, Vitamin C, and Vitamin E and Cardiovascular Diseases Beyond Cholesterol Lowering-Deciphering the Benefits of Dietary Intervention on Cardiovascular Diseases Biologic Alternatives to Stents and Grafts Bivalirudin for Percutaneous Coronary Intervention and in Acute Coronary Syndromes Cardiac Markers in the Diagnosis of Acute Coronary Syndromes Cardiomyopathy and Embolization-Risks and Benefits of Anticoagulation in Sinus Rhythm Catheter Ablation of Ventricular Tachycardia Related to Coronary Artery Disease-The Role of Noncontact Mapping Chlamydia Pneumoniae and Atherosclerosis Clinical and Interventional Electrophysiology Clinical Characteristics and Catheter Ablation of Left Ventricular Outflow Tract Tachycardia Clinical Implications of Elevated Lipoprotein(a) Clinical Trial Evidence for the Cardioprotective Effects of Omega-3 Fatty Acids Clinical Trials in Gene Therapy Closed Chest Totally Endoscopic Coronary Artery Bypass Surgery-Fantasy or Reality Colchicine Treatment for Recurrent Pericarditis Combination Lipid-Altering Therapy-An Emerging Treatment Paradigm for the 21st Century Complex Connection Between CD36 and Atherosclerosis, Lipid Metabolism, and Insulin Resistance Syndromes Complications of Oral Antiplatelet Medications Congenital Heart Disease-Current Indications for Antithrombotic Therapy in Pediatric Patients Congenital Heart Disease Constraint-Induced Movement Therapy to Enhance Recovery after Stroke Controversies about Tissue Plasminogen Activator-Extending the Window of Therapy Coronary Anastomotic Devices-Theory and Patented Ideas on Micromechanical Fastening Coronary Heart Disease-Clinical Trials Review Current Issues of Gene Therapy for Cardiovascular Disorders and Antithrombotic Therapy in Chronic Heart Disease Current Management of Patients with Pulmonary Hypertension and Right Ventricular Insufficiency Atherogenesis and the Arginine Hypothesis Plaque Angiogenesis and Atherosclerosis Primary Prevention of Heart Disease in Women The Need for Medicine-Based Evidence As Well as Evidence-Based Medicine Deactivation of the Sympathetic Nervous System in Patients with Chronic Congestive Heart Failure Deep Venous Thrombosis Prophylaxis in Patients with Heart Disease Diabetes and Cardiovascular Disease Diabetes-Statins, Fibrates, or Both Diagnosis and Treatment of Hyperhomocysteinemia Diastolic Function in Hypertension Diastolic Heart Failure in the Community Diet and Coronary Heart Disease-Clinical Trials Diet and Pharmacologic Therapy of Obesity to Modify Atherosclerosis Dietary Fiber Prevents Carbohydrate-induced Hypertriglyceridemia Differences in Outcome Between Percutaneous Coronary Intervention and Coronary Bypass Grafting Differentiation in the Angiotensin II Receptor 1 Blocker Class on Autonomic Function Dilated Cardiomyopathy Effects of Fish Oils and Fish on Cardiovascular Disease Effects of Neurohormonal Antagonism on Pathologic Left Ventricular Remodeling in Heart Failure Electron Beam Tomography As an Endpoint for Clinical Trials of Antiatherosclerotic Therapy Emerging Indications for Permanent Pacing Endothelial Function As a Therapeutic Target in Coronary Artery Disease Epidemiology and Pathophysiology of Heart Failure Epidemiology and Pathophysiology of Heart Failure-1 Evolving Technology for Coronary and Valvular Surgery Failing Energetics in Failing Hearts Functional Foods and Cardiovascular Disease Gene-Diet Interaction and Plasma Lipid Response to Dietary Intervention Genes and Environment in Type 2 Diabetes and Atherosclerosis in Aboriginal Canadians Genetic Counseling for Congenital Heart Disease-New Approaches for a New Decade Genetics of Atherosclerosis-The Search for Genes Acting At the Level of the Vessel Wall Genetics of Venous and Arterial Thromboembolism Genomics and the Pathophysiology of Heart Failure Global Risk Assessment for Lipid Therapy to Prevent Coronary Heart Disease Good Smooth Muscle Cells in Atherosclerosis Guidelines for the Acute Coronary Syndromes Heart Failure in Blacks-Etiologic and Epidemiologic Differences Herbs and Atherosclerosis High-density Lipoprotein Metabolism-Molecular Targets for New Therapies for Atherosclerosis Hormone Replacement Therapy and Cardiovascular Risk Hormone Replacement Therapy for Prevention of Coronary Heart Disease-Current Evidence Hormone Replacement Therapy in the Prevention and Treatment of Atherosclerosis Hyperglycemia and Cardiovascular Disease Hypertrophic Cardiomyopathy Imaging Techniques to Predict Cardiovascular Risk Implantable Dual-Chamber Cardioverter-Defibrillator-Pacemaker Implications of Recent Heart Failure Trials for Patients with Hypertension Implications of the Atorvastatin Versus Revascularization Treatment (AVERT) Study for the Clinician Insulin Resistance in Human Partial Lipodystrophy Is There a Role for Calcium Channel Blockers in Congestive Heart Failure Ischemic Heart Disease Issues and Challenges with Antithrombotic Therapy in Diabetic Patients with Acute Coronary Syndromes Leadership in Academic Medicine-A Personal Perspective Levosimendan-A Promising Agent for the Treatment of Hospitalized Patients with Decompensated Heart Failure Low Molecular Weight Heparins and Coronary Artery Disease Low-Density Lipoprotein Apheresis in the Treatment of Atherosclerosis and Other Potential Uses Low-level Inotropic Stimulation with Type III Phosphodiesterase Inhibitors in Patients with Advanced Symptomatic Chronic Heart Failure Receiving b-blocking Agents Low-Molecular Weight Heparins in Coronary Artery Disease Management of Atrial Flutter Management of Heart Failure Management of Ventricular Arrhythmias in Adults with Congenital Heart Disease Management of Ventricular Arrhythmias Management of Ventricular Tachycardia in Patients with Clinically Normal Hearts Measurement of Cholesterol in Plasma and Other Body Fluids Medical Treatment of Hypertrophic Cardiomyopathy Methods of Minimizing Inappropriate Implantable Cardioverter-Defibrillator Shocks Minimal Access Aortic Root, Valve, and Complex Ascending Aortic Surgery Minimal Access Reoperative Mitral and Aortic Valve Surgery Mitral Ring Annuloplasty-An Incomplete Correction of Functional Mitral Regurgitation Associated with Left Ventricular Remodeling Myocardial Matrix and the Development and Progression of Ventricular Remodeling Natriuretic Peptides in the Pathophysiology of Congestive Heart Failure New Concepts in Fibrinolysis and Angiogenesis New Concepts in Vascular Nitric Oxide Signaling New Developments in Atherosclerosis Imaging-Electron Beam Tomography New Developments in the Detection of Vulnerable Plaque New Developments in the Prevention of Atherosclerosis in Patients with Low High-density Lipoprotein Cholesterol New Statins and New Doses of Older Statins Novel Inhibitors of Factor X for Use in Cardiovascular Diseases Novel Neurohumoral Factors in Congestive Heart Failure-Adrenomedullin Nutritional Interventions in Cardiovascular Disease-New Challenges and Opportunities Optimal Dietary Strategy to Manage Risk Associated with Various Dyslipidemias Oral Glycoprotein IIb-IIIa Antagonists in Coronary Artery Disease Oral Platelet Glycoprotein IIb-IIIa Inhibition Oxidative Stress in Congestive Heart Failure Pacemakers and Defibrillators for Congestive Heart Failure Pathophysiologic Mechanisms in Pericardial Disease Pathophysiology and Treatment of The Dyslipidemia of Insulin Resistance Pathophysiology of Atherosclerosis-Development, Regression, Restenosis Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction Percutaneous Coronary Intervention Versus Medical Therapy for Coronary Heart Disease Percutaneous Transluminal Septal Myocardial Ablation Peroxisome Proliferator-activated Receptors in Vascular Biology and Atherosclerosis-Emerging Insights for Evolving Paradigms Perspectives on Cardiac Allograft Vasculopathy Platelet Activation in Acute Myocardial Infarction and the Rationale for Combination Therapy Platelet Glycoprotein IIb-IIIa Inhibitors for Acute Coronary Syndromes-Initiate Treatment Early or Wait for the Catheterization Laboratory Platelet Glycoprotein Receptor Site Blockade in Coronary Artery Disease Platelet-Endothelial Interactions in Atherosclerosis Post-Stroke Depression-An Update Post-Stroke Epilepsy potential of the Angiotensin II Receptor 1 Blocker Eprosartan in the Management of Patients with Hypertension or Heart Failure Potential Use of Ca Scanning to Determine the Need for and Intensity of Lipid-lowering Therapy in Asymptomatic Adults Power of Food to Improve Multiple Cardiovascular Risk Factors Prevention of Restenosis with Intravascular beta-Radiotherapy Prevention of Ventricular Arrhythmias in the Congenital Long QT Syndrome Prevenzione Trial on Fish Oil and Vitamin E Supplementation in Myocardial Infarction Survivors Primary Prevention of Coronary Heart Disease Prophylactic Defibrillator Implantation in Patients with Coronary Artery Disease Radiofrequency Catheter Ablation of Atrial Fibrillation Initiated by Spontaneous Ectopic Beats Rational Use of Inotropic Therapy in Heart Failure Recent Developments in Microvascular Angina Recent Role of Imaging in the Diagnosis of Pericardial Disease Regulation of Cell Migration in Atherosclerosis Renin Angiotensin System As a Risk Factor for Coronary Artery Disease Results of the Assessment of Treatment with Lisinopril and Survival Trial Role of Angiotensin-converting Enzyme Inhibitors in the Treatment of Hypertension Role of Chemokines in Atherosclerosis Role of C-Reactive Protein in Cardiovascular Disease Risk Role of Diet in the Prevention and Treatment of Hypertension Role of Endothelin Receptor Antagonists in the Treatment of Chronic Heart Failure Role of Fibric Acids in Atherosclerosis Role of Lipoprotein(a) in the Pathogenesis of Atherosclerotic Cardiovascular Disease and Its Utility as Predictor of Coronary Heart Disease Events Role of Lipoprotein[a] in Atherosclerosis Role of Nitrogen Oxides on Eicosanoid Production During Atherosclerosis-Understanding the Controversies Role of Pharmacologic Treatment to Prevent Sudden Death in the Implantable Cardioverter Defibrillator Era Selective or Nonselective b-Adrenergic Blockade in Patients with Congestive Heart Failure Serum Uric Acid Is Not an Independent Risk Factor for Coronary Heart Disease Should Patients with Asymptomatic Wolff-Parkinson-White Pattern Undergo a Catheter Ablation Soy Proteins and Cardiovascular Disease Statin Therapy and Prevention of Stroke Statin Trials in Progress-Unanswered Questions Statins in Children-What Do We Know and What Do We Need to Do Statins, Hormones, and Women-Benefits and Drawbacks for Atherosclerosis and Osteoporosis Strategies for Catheter Ablation of Scar-related Ventricular Tachycardia Stress Echocardiography in the Diagnosis of Coronary Artery Disease Stroke and Cognition Stroke Prevention in Atrial Fibrillation Surgical Alternatives to Transplantation and Assist Devices in the Treatment of Heart Failure Sympathetic Overactivity in Hypertension-A Risk Factor for Cardiovascular Disease Systolic Hypertension and Cardiovascular Risk Reduction-A Clinical Review Targeting Triglycerides as Prognostic Indicators and Determining Lowest Values for Patient Benefit The Definitions of Acute Coronary Syndrome, Myocardial Infarction, and Unstable Angina The Risk of Congestive Heart Failure-Sobering Lessons from the Framingham Heart Study The Role of Fibric Acid Derivatives in the Secondary Prevention of Coronary Heart Disease The Role of Tumor Necrosis Factor Alpha in the Pathophysiology of Congestive Heart Failure Therapeutic Angiogenesis-Theoretic Problems Using Vascular Endothelial Growth Factor Therapeutic Implications of Escape from Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Heart Failure Therapeutic Modulation of Cellular Cholesterol Efflux Therapeutic Options in Patients with Reduced Ejection Fraction and Nonsustained Ventricular Tachycardia To Define Is Divine Translating Heart Failure Guidelines into Clinical Practice-Clinical Science and the Art of Medicine Treating Ambulatory Ischemia in Coronary Disease by Manipulating the Cell Biology of Atherosclerosis Treatment of Coexisting Diabetes and Hypertension Treatment of Dyslipidemia in Pre-and Postmenopausal Women With and Without Known Atherosclerotic Cardiovascular Disease Treatment Strategies for Microvascular Dysfunction Following Acute Myocardial Infarction Trial Report-Plant Phytoestrogens Reduce the Risk of Coronary Heart Disease Trial Report-Some Implications from the Hypertension Optimal Treatment Study for Recent Recommendations Concerning Guidelines for the Treatment of Hypertension Triglyceride, Small, Dense Low-density Lipoprotein, and the Atherogenic Lipoprotein Phenotype Use of Statins in Acute Coronary Syndromes-The Mechanisms Behind the Outcomes Utility of Intracardiac Echocardiography in Interventional Electrophysiology Vectors for Gene Therapy of Cardiovascular Disease Development and Assessment of Antiatherosclerotic Therapies Beyond Low-density Lipoprotein Cholesterol and Blood Pressure Ventricular Arrhythmias, Sudden Death, and Prevention in Patients with Hypertrophic Cardiomyopathy Ventricular Tachycardia Catheter Ablation in Arrhythmogenic Right Ventricular Dysplasia-A 16-year Experience Ventricular Unloading and Myocyte Recovery-Insight Gained into the Pathophysiology of Congestive Heart Failure Weighing the Evidence for Infection as a Risk Factor for Coronary Heart Disease What Has Intravascular Ultrasound Taught Us About Plaque Biology What Niche Will Newer Class III Antiarrhythmic Drugs Occupy Will the Real Heart-healthy Diet Please Stand Up!
更新于 2002-02-10
